<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
        <!-- first mobile meta -->
        <meta name="viewport" content="width=device-width,initial-scale=1">
        <title>Central Blood Bank</title>
         <link rel="stylesheet" href="css/bootstrap.css">
        <link rel="stylesheet" href="css/Finaltest.css"> 
       <link href="https://fonts.googleapis.com/css?family=Righteous" rel="stylesheet">
       <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
    </head>
    <body>
        <!-- start navbar -->
        <nav class="navbar navbar-inverse navbar-fixed-top" role="navigation">
                  <div class="container">
                        <!-- Brand and toggle mobile display -->
                        <div class="navbar-header">
                              <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false">
                                <span class="sr-only">Toggle navigation</span>
                                <span class="icon-bar"></span>
                                <span class="icon-bar"></span>
                                <span class="icon-bar"></span>
                              </button>
                           <a class="navbar-brand" href="#">Central <span>Blood</span> Bank</a>
                        </div>
                      
                        <!-- Navbr Links -->
                        <div class="collapse navbar-collapse" id="bs-example-navbar-collapse-1">
                              <ul class="nav navbar-nav navbar-right">
                                    <li class="active"><a href="Finaltest.html"> Home </a></li>
                                    <li><a href="Facts.html">Facts</a></li>
                                     <li><a href="Medecine.html">Medecine</a></li>
                                  
                                    <li class="dropdown">
                                          <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Retail<span class="caret"></span></a>
                                          <ul class="dropdown-menu">
                                                <li><a href="Cairo.html">Cairo</a></li>
                                                <li><a href="Alex.html">Alex</a></li>
                                                <li><a href="Giza.html">Giza</a></li>
                                          </ul>
                                    </li>
                                    <li><a href="Signup.html">Signup</a></li>
                                    <li><a href="login.html">Login</a></li>
                              </ul>
                        </div>
              </div><!--End of thecontainer -->
     </nav>
        
        
         <div class="container" style="margin-top:20px; padding-top:60px;">
				<div class="thumbnail">
					<img src="images/medecine/darbepoetin.png" alt="..." style="padding-top:50px;" >
                    <p class="text-info" style="padding-top:50px;">
                        Darbepoetin alfa (INN) /dɑːrbəˈpoʊɪtɪn/ is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Darbepoetin is marketed by Amgen under the trade name Aranesp.
                    </p>
					<div class="caption">
						<a class="btn btn-primary" role="button" data-toggle="collapse" href="#collapseExample1_1" aria-expanded="false" aria-controls="collapseExample1_1">
							More..
						</a>
						<div class="collapse" id="collapseExample1_1">
							<div class="well">
								<p> 
                                    The drug was approved in September 2001 by the Food and Drug Administration for treatment of anemia in patients with chronic renal failure by intravenous or subcutaneous injection.[1] In June 2001, it had been approved by the European Medicines Agency for this indication as well as the treatment of anemia in cancer patients undergoing chemotherapy.[2]Dr. Reddy's Laboratories launched darbepoetin alfa in India under the brand name ‘Cresp’ in August 2010. This is the world’s first follow-on biologic of darbepoetin alfa.
                                    Darbepoetin is produced by recombinant DNA technology in modified Chinese hamster ovary cells.[3] It differs from endogenous erythropoietin (EPO) by containing two more N-linked oligosaccharide chains. It is an erythropoiesis-stimulating 165-amino acid protein.
                                </p>
							</div>
						</div>

					</div>
				</div>
			</div>

	        

	        <div class="container">
				<div class="thumbnail">
					<img src="images/medecine/oxymetholonet.jpg" alt="..." style="padding-bottom:20px;">
                    <p class="text-info">
                       Oxymetholone, sold under the brand names Anadrol and Anapolon among others, is an androgen and anabolic steroid (AAS) medication which is used primarily in the treatment of anemia. It is also used to treat osteoporosis, HIV/AIDS wasting syndrome, and to promote weight gain and muscle growth in certain situations. It is taken by mouth. 
                    </p>
					<div class="caption">
						<a class="btn btn-primary" role="button" data-toggle="collapse" href="#collapseExample1_3" aria-expanded="false" aria-controls="collapseExample1_3">
							More..
						</a>
						<div class="collapse" id="collapseExample1_3">
							<div class="well">
								<p> 
                                    Side effects of oxymetholone include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. It can also cause liver damage. The drug is a synthetic androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). It has strong anabolic effects and weak androgenic effects. 
                                    Oxymetholone was first described in 1959 and was introduced for medical use by 1961. It is used mostly in the United States. In addition to its medical use, oxymetholone is used to improve physique and performance. The drug is a controlled substance in many countries and so non-medical use is generally illicit. 

                                </p>
							</div>
						</div>

					</div>
				</div>
			</div>
        
        <div class="container">
				<div class="thumbnail">
					<img src="images/medecine/flucloxacillintest.jpg" alt="...">
                    <p class="text-info">
                       Flucloxacillin (INN) or floxacillin (USAN) is a narrow-spectrum beta-lactam antibiotic of the penicillin class. It is used to treat infections caused by susceptible Gram-positive bacteria. 
                    </p>
					<div class="caption">
						<a class="btn btn-primary" role="button" data-toggle="collapse" href="#collapseExample1_4" aria-expanded="false" aria-controls="collapseExample1_4">
							More..
						</a>
						<div class="collapse" id="collapseExample1_4">
							<div class="well">
								<p> 
                                    . Unlike other penicillins, flucloxacillin has activity against beta-lactamase-producing organisms such as Staphylococcus aureus as it is beta-lactamase stable. However, it is ineffective against methicillin-resistant Staphylococcus aureus (MRSA). It is very similar to dicloxacillin; they are considered interchangeable. While no longer used in the United States, Flucloxacillin is supplied under a variety of trade names in other countries, including Floxapen (Beecham, now GSK), Flopen (CSL), Staphylex (Alphapharm), Softapen (Rephco Pharmaceuticals Limited), Flubex (Beximco Pharmaceuticals Ltd, Bangladesh), and Flupen (for state use only in South Africa). 

                                </p>
							</div>
						</div>

					</div>
				</div>
			</div>
        <div class="container">
				<div class="thumbnail">
					<img src="images/medecine/Med3.jpg" alt="...">
                    <p class="text-info">
                       Iron(II) fumarate, also known as ferrous fumarate, is the iron(II) salt of fumaric acid, occurring as a reddish-orange powder, used to supplement iron intake. It has the chemical formula C4H2FeO4. Pure ferrous fumarate has an iron content of 32.87%, therefore one tablet of 300 mg iron fumarate will contain 98.6 mg of iron (548% Daily Value based on 18 mg RDI). 
                    </p>
					
				</div>
			</div>
        <div class="container">
				<div class="thumbnail">
					<img src="images/medecine/Filgrastim.jpg" alt="...">
                    <p class="text-info">
                        Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low blood neutrophils due to a number of causes. This includes when it occurs following chemotherapy, radiation poisoning, HIV/AIDS, or is of unknown cause. It may also be used to increase white blood cells for gathering during leukapheresis. It is given either by injection into a vein or under the skin.
                    </p>
					<div class="caption">
						<a class="btn btn-primary" role="button" data-toggle="collapse" href="#collapseExample1_2" aria-expanded="false" aria-controls="collapseExample1_2">
							More..
						</a>
						<div class="collapse" id="collapseExample1_2">
							<div class="well">
								<p> 
                                    Common side effects include fever, cough, chest pain, joint pain, vomiting, and hair loss. Severe side effects include splenic ruptureand allergic reactions. It is unclear if use in pregnancy is safe for the baby. Filgrastim is similar to naturally occurring granulocyte colony-stimulating factor (G-CSF). 
                                    Filgrastim was approved for medical use in the United States in 1991. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is about US$3.95 to US$94.66 per dose. In the United Kingdom it cost the NIH about £50.15 per 300 ug dose. In the United States treatment costs more than US$200. Biosimilars are available.

                                </p>
							</div>
						</div>

					</div>
				</div>
			</div>
               <!--start footer -->
       <footer class="continer-fluid text-center" >
        <div class="row">
            <div class="col-sm-12">
                <h3>Contact</h3>
                <a href="https://www.facebook.com" class="fa fa-facebook " target="_blank"></a>
                <a href="https://www.twitter.com" class="fa fa-twitter" target="_blank"></a>
                <a href="https://www.youtube.com" class="fa fa-youtube" target="_blank"></a>
                <a href="https://www.instagram.com" class="fa fa-instagram" target="_blank"></a>
                <a href="https:www.pinterest.com" class="fa fa-pinterest" target="_blank"></a>
                <h6>All Rights Reserved © 2017</h6>
                
            </div>
        </div>
    </footer>
        <!--end footer -->
         
        <script src="js/jquery.min.js"></script>
        <script src="js/bootstrap.min.js"></script> 
    </body>